Avacta Group has appointed Dr Eliot Forster as non-executive chairman to the Board. Dr Trevor Nichols, who has acted as chairman of the Board since January 2014, will remain on the Board as a non-executive director. Eliot brings over 25 years of experience in the pharmaceutical and biotechnology industry, most recently leading Immunocore as CEO to become a world-leading immuno-oncology biotech, raising over £230 million in equity and non-dilutive funding as well as securing partnerships with AstraZeneca and the Bill & Melinda Gates Foundation. The early part of his career was at GSK and then he went on to hold a number of senior roles in Pfizer where he became head of development and operations for the EU and Asia.